What it is used for

Treatment of Type 2 diabetes mellitus inadequately controlled by diet and exercise: as monotherapy; as dual therapy to improve glycaemic control: in combination with metformin or sulfonylurea, in combination with insulin; as triple therapy to improve glycaemic control: in combination with metformin and sulfonylurea.

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

• The way to take this medicine: Oral
• Store below 30 degrees Celsius
• Shelf lifetime is 3 Years.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White to off-white, round, biconvex, uncoated tablet embossed with '45' on one side

Food interactions

For the active ingredient pioglitazone

• Take without regard to meals. Food slightly delays absorption rate but extent of absorption is not affected.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

• pioglitazone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient pioglitazone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What it is used for

Treatment of Type 2 diabetes mellitus inadequately controlled by diet and exercise: as monotherapy; as dual therapy to improve glycaemic control: in combination with metformin or sulfonylurea, in combination with insulin; as triple therapy to improve glycaemic control: in combination with metformin and sulfonylurea.

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

• The way to take this medicine: Oral
• Store below 30 degrees Celsius
• Shelf lifetime is 3 Years.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

WWhite to off-white, round, biconvex, uncoated tablet embossed with '15' on one side

Food interactions

For the active ingredient pioglitazone

• Take without regard to meals. Food slightly delays absorption rate but extent of absorption is not affected.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Over 65?

This medicine contains the active ingredients:

• pioglitazone

If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.

Pregnant or planning a pregnancy?

For the active ingredient pioglitazone

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.